OFIX
Orthofix Medical Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.71
+0.81%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$8.50
From 52W high−46.33%
Volume610131.00
Market cap$354.78M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$8.50
From 52W high
−46.33%
Volume
610131.00
Market cap
$354.78M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.5x
P/E (TTM)
—
RSI (14)
33.4
MomentumView details →
1D Return
+0.81%
YTD Return
−42.55%
SummaryUpdated Jun 1, 2026
Orthofix Medical Inc. (NASDAQ:OFIX) is a medical device and biologics company founded in 1980 and headquartered in Lewisville, Texas. The company went public in 1992 and has evolved through strategic acquisitions, most notably its merger with SeaSpine in January 2023, which significantly expanded its spine product portfolio. Orthofix operates globally across the United States, Europe, and other international markets, focusing on orthopedic and spine medical solutions. The company has undergone significant transformation in recent years, including a name change from Orthofix International N.V. in 2018 and strategic portfolio optimization to focus on higher-growth, more profitable product lines.
Similar companies
Latest newsMore news →
Orthofix Medical Inc. reported Q2 2026 net sales of $210.9 million, a 3.8% year-over-year increase, with a GAAP net loss of $15.8 million and diluted EPS of -$0.39.47d agoOrthofix Medical Inc. elected Alan L. Bazaar, Wayne Burris, Massimo Calafiore, Vickie L. Capps, and Michael M. Finegan as directors effective June 10, 2026.102d ago